Handelsbanken Fonder AB - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 159 filers reported holding REVANCE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$155
-54.7%
13,5000.0%0.00%
-50.0%
Q2 2023$342
-6.0%
13,500
+19.5%
0.00%0.0%
Q1 2023$364
+74.2%
11,3000.0%0.00%
+100.0%
Q4 2022$209
-99.9%
11,300
+18.9%
0.00%
-50.0%
Q3 2022$256,000
-2.7%
9,500
-41.0%
0.00%
+100.0%
Q4 2021$263,000
-41.4%
16,1000.0%0.00%
-50.0%
Q3 2021$449,000
-5.9%
16,1000.0%0.00%0.0%
Q2 2021$477,00016,1000.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Palo Alto Investors LP 4,405,039$118,936,0009.40%
Essex Woodlands Management, Inc. 457,085$12,341,0005.10%
Evolutionary Tree Capital Management, LLC 191,868$5,180,0004.98%
Ghost Tree Capital, LLC 390,000$10,530,0002.96%
Antara Capital LP 4,069,400$109,874,0002.90%
RICE HALL JAMES & ASSOCIATES, LLC 896,754$24,212,0001.40%
Jericho Capital Asset Management L.P. 714,000$19,278,0001.22%
Antara Capital LP 1,600,000$43,200,0001.14%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 120,000$3,240,0001.04%
TANG CAPITAL MANAGEMENT LLC 287,500$7,763,0000.95%
View complete list of REVANCE THERAPEUTICS INC shareholders